BC Cancer Foundation

150 - 686 West Broadway
Vancouver, BC V5Z 1G1
President & CEO: Sarah Roth
Board Chair: Andrew Sweeney

Website: www.bccancerfoundation.com
Charitable Reg. #: 11881 8434 RR0001
Sector: Health - Cancer
Operating Charity

Results Reporting

Grade: B

The grade is based on the charity's public reporting of the work it does and the results it achieves.

Financial Transparency

Audited financial statements for current and previous years available on the charity's website [Audited financial statement for most recent year]

Need for Funding

Funding Reserves Program Costs

Spending Breakdown

Cents to the Cause

95¢
75¢
avg
65¢
50¢
2016 2017 2018
For a dollar donated, cents funding the cause after fundraising and admin costs, excluding surplus.

Full-time staff #69

Avg. Compensation $92,818

Top 10 Staff Salary Range

$350k + 1
$300k - $350k 1
$250k - $300k 0
$200k - $250k 1
$160k - $200k 3
$120k - $160k 4
$80k - $120k 0
$40k - $80k 0
< $40k 0
Information from most recent CRA Charities Directorate filings for F2018

About BC Cancer Foundation:

Founded in 1967, BC Cancer Foundation (BCCF) raises money for BC Cancer Agency. The foundation funds research, patient care, and major equipment purchases. BC Cancer Foundation reports distributing $25.6m in grants in F2018 – 75% for research and education, 19% for equipment, and 6% for patient care. The money funded six BC Cancer Centres in Kelowna, Abbotsford, Vancouver, Victoria, Surrey, and Prince George.

BC Cancer Foundation funded 396 research projects in F2018. Researchers at BC Cancer - Victoria are working on a new oncogene-targeted T cell therapy to improve health outcomes for lymphoid cancer patients at risk of relapse. Also launched in 2018, Enhanced Pancreatic Cancer Profiling for Individualized Care is a Canada-wide research initiative on pancreatic cancer biology that sequences pancreatic tumors to develop new treatment options. BC Cancer’s flagship study in precision medicine, called Personalized Onco-Genomics (POG), looks at genomes of metastatic cancer patients to find cancer-driving genetic markers and identify individualized treatment options. As of September 2017, over 900 people are enrolled in POG and 50 types of cancer have been studied.

One of BCCF’s major equipment purchases in 2018 was a PET/CT scanner for BC Cancer - Victoria. PET/CT scanners save patients from unnecessary radiation, surgery, imaging tests and biopsies. There are currently two PET/CT scanners operating in BC (both in Vancouver). BCCF is campaigning to buy and install three scanners in Kelowna, Victoria, and Vancouver. According to BCCF’s website, the campaigns for Victoria and Kelowna are complete.

Results and Impact: In May 2019, BC Cancer researchers published a paper in Clinical Cancer Research demonstrating how they improved health outcomes of patients with advanced pancreatic cancer using lung cancer therapies. They made this treatment decision after identifying a rare genetic trait in advanced pancreatic cancer patients that resembled other cancer types and was potentially treatable. BC Cancer – Kelowna cured 75 breast cancer patients using a new brachytherapy technique that delivers radiation treatment internally using 'seed' implants, as opposed to traditional external radiation. The foundation states that BC Cancer - Kelowna is a national leader in this specialized form of radiation treatment. 

Financial Review:

BC Cancer Foundation is a Major 100 charity with $49.7m in donations and special events fundraising in F2018. Administrative costs are 6% of revenues (excluding investment income) and fundraising costs are 26% of donations and fundraising. Per dollar donated to BCCF, 68 cents go towards its grants, which falls within Ci’s reasonable range for overhead spending.

Funding reserves of $146m include $56.6m in endowed funds. BC Cancer Foundation does not specify how much of these funds are donor-endowed. Including all endowed funds, BCCF can cover annual grants to BC Cancer Agency for 5 and a half years.

BC Cancer Foundation reported using external fundraisers in its 2018 T3010 CRA filing. In F2018, BCCF paid $1m to external fundraisers that raised $2.5m. This produces an external fundraising ratio of 41% – BCCF received 59 cents of every dollar donated to external fundraisers.

Fundraising revenues per full-time staff member were $721k in F2108. With an average full-time salary of $93k, each dollar paid in compensation brought in $8 of fundraising.

This charity report is an update that has been sent to BC Cancer Foundation for review. Comments and edits may be forthcoming.

Updated on May 17, 2019 by Katie Khodawandi.

Financial Ratios

Fiscal year ending March
201820172016
Administrative costs as % of revenues 5.8%5.8%5.7%
Fundraising costs as % of donations 25.8%27.9%33.1%
Program cost coverage (%) 554.3%387.0%531.4%

Summary Financial Statements

All figures in $000s
201820172016
Donations 39,02035,86031,136
Special events 10,7229,2059,973
Investment income 4,7894,8346,488
Other income 7031,8541,687
Total revenues 55,23451,75349,284
Grants 26,34834,56024,031
Administrative costs 2,9212,7312,443
Fundraising costs 12,83512,59013,612
Cash flow from operations 13,1301,8729,198
Funding reserves 146,035133,730127,709
Note: Ci reported community awareness expenses in fundraising costs, increasing fundraising by $1.5m in F2018, $1.5m in F2017 an $1.7m in F2016. Ci adjusted for changes in amounts payable to BC Cancer, affecting grants by $721k in F2018, $6.3m in F2017, and ($3.1m) in F2016. Ci reported amortization as a non-cash expense and shifted it out of administrative costs. Ci reported funds held at Vancouver Foundation at fair value in funding reserves.

Comments added by the Charity:

No comments have been added by charity
Go to top